三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图表262025年中国双抗领域上市新药
图表262025年中国双抗领域上市新药
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:160KB
图片尺寸:1659*1095
同报告图片
/
4
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
fCDnsbvliKsgICAgICAgICAgIHwg5Y2g5q+UIHwKfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tfAp8IOWPjOaKl0FEQyAgICAgICAgfCA1MSUgIHwKfCBBT0MgICAgICAgICAgICB8IDE1JSAgfAp8IERBQyAgICAgICAgICAgIHwgMTAlICB8Cnwg5oqX5L2T54mH5q615YG257uD54mpIHwgOCUgICB8Cnwg5Y+M6L296I23QURDICAgICAgfCAxMyUgIHwKfCDlj4zovb3ojbflj4zmipdBREMgIHwgMyUgICB8CgrotYTmlpnmnaXmupDvvJrkuJzlkLTor4HliLjjgIHoja/mmI7lurflvrc=
fCDliIbmnpDnsbvlnosgICAgICAgICB8IE4gICB8IEVHNTAx5Z2H5YC8zpQgfCDlronmhbDliYLlnYflgLzOlCB8CnwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18Cnwg5a6M5oiQ6ICF5YiG5p6QICAgICAgIHwgNDMgIHwgMTAuNSAgICAgICB8IDQuMyAgICAgICAgIHwKfCBJVFQgLSBNQVLliIbmnpAgICAgfCA1NiAgfCAxMC40ICAgICAgIHwgNC40ICAgICAgICAgfAoK5pWw5o2u5p2l5rqQ77ya5Z+D5qC85p6X5Yy76I2v5L6b5Zu+
所属报告:
动脉智库:2025创新药及供应链年度创新白皮书:分化加速行业回归平台与产品价值(90页).pdf
打包全文图表
相关数据
美国II期经治患者伏罗尼布减少了抗VEGF注射
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
收藏
行业数据
2026-07-03
原图定位
查看详情
全球已有多款抗VEGF注射剂产品获批上市
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
收藏
行业数据
2026-07-03
原图定位
查看详情
2024年中国前10大高端护肤品牌按抗皱紧致类护肤品零
收藏
行业数据
2026-06-25
原图定位
查看详情
2020~2029年中国高端抗皱紧致类护肤品行业市场规模
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
收藏
市场规模
2026-06-25
原图定位
查看详情
抗疱疹病毒产业链
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
收藏
产业链
2026-05-28
原图定位
查看详情
2016-2030E中国眼底疾病抗VEGF单抗药物市场规模及增速
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
收藏
市场规模
2026-05-09
原图定位
查看详情
免疫双抗胃癌的竞争格局(2期临床及以上)
收藏
竞争格局
2026-04-20
原图定位
查看详情
全球抗HDV药物市场规模(亿美元)
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
收藏
市场规模
2026-04-13
原图定位
查看详情
抗HBV药物目标市场规模,2019-2034E(亿美元)
收藏
市场规模
2026-04-13
原图定位
查看详情
全球用于治疗CHB的临床开发中的抗HBVsiRNA候选药物(2期或以上)
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
收藏
行业数据
2026-04-13
原图定位
查看详情
全球用于治疗CHD的临床开发中的抗HDVsiRNA候选药物
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
收藏
行业数据
2026-04-13
原图定位
查看详情
康方生物带动中国PD-(L)1/VEGF双抗出海浪潮
收藏
行业数据
2026-03-31
原图定位
查看详情
美国对中国双反加征高额税率
收藏
行业数据
2026-03-31
原图定位
查看详情
PD-(L)1/VEGF双抗竞争格局全览
收藏
竞争格局
2026-03-31
原图定位
查看详情
相较于PD-(L)1抑制剂,PD-(L)1/VEGF双抗有极大替代和拓展空间
收藏
行业数据
2026-03-31
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
另一方面,中国药企在双抗领域的突破不仅体现在产品创新上,更体现在商业模 式的升级。三生制药与辉瑞达成的60.5亿美元授权合作,创下中国创新药出海 新纪录;岸迈生物通过FIT-lg?技术平台实现从“产品研发"到“技术输出"的商业模 式创新。 2025年是中国双抗临床转化的丰收年。获批上市方面,康方生物PD-1/VEGF 双抗依沃西单抗拿下NSCLC一线适应症,成为全球首个获批的 PD-1/VEGF双 抗,凌腾医药EPCAM/CD3双抗卡妥索单抗在欧盟获批,百济神州HER2 双抗泽 尼达妥单抗填补胆道癌治疗空白,三大产品覆盖肿瘤免疫、实体瘤、实体瘤腹水 三大场景。上市申请端,石药/康宁杰瑞HER2双抗 KN026、艾伯维CD20×CD3 双抗艾可瑞妥单抗、百济神州/安进 DLL3/CD3双抗塔拉妥单抗均已进入NDA 临床获批端呈现两大趋势。一是适应症拓展,康方生物IL-4Rα/ST2 双抗AK139 信达生物IL-4Rα/TSLP双抗IBI3002 进军COPD、哮喘等呼吸系统疾病领域,华 东医药OX40L/TNFα双抗HDM3019瞄准类风湿关节炎,显示双抗适应症从肿瘤 向自免等更大蓝海延伸;二是技术迭代,百奥泰 PD-1/4-1BB 双抗 BAT7111、
行业数据
原图定位
当前图表所属:
动脉智库:2025创新药及供应链年度创新白皮书:分化加速行业回归平台与产品价值(90页).pdf
图表57全球新型ADC细分类别
图表56技术趋势总览
按公司名首字母排序
RBANS总分变化比较:完成者vS.ITT-MAR(p=0.032VS.0.012;调整β=4.75VS.4.67)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》